Financials
- Market Capitalization 332.1 M
- Employee 35
- Founded 2008
- CEO N/A
- Website www.inhibikase.com
- Headquarter Delaware, United States
- FIGI BBG005TP2339
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.61
Relación precio/flujo de caja
54.94
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3194 | FHTX Foghorn Therapeutics Inc. - Common Stock | 5.69 USD | -0.87% | -16.93% | +25.05% | +39.46% | 337.90 M USD | ||
| 3197 | SABS SAB Biotherapeutics, Inc. - Common Stock | 3.70 USD | -0.27% | -2.63% | +3.06% | +79.61% | 336.65 M USD | ||
| 3221 | VNDA Vanda Pharmaceuticals Inc. - Common Stock | 5.42 USD | +0.37% | -0.18% | +6.27% | -1.99% | 327.71 M USD | ||
| 3250 | IRD Opus Genetics, Inc. - Common Stock | 3.83 USD | +5.80% | -7.71% | +2.96% | +2.96% | 318.64 M USD |